Achieving Targeted Delivery of Drugs to Uterine Muscle in Women for the Prevention of Preterm Labour

我们拥有针对子宫的专利脂质体，这使我们能够将药物专门输送到子宫的肌肉细胞，从而增加安全性。脂质体可以装载阻止或促进宫缩的药物，创造出一种多功能的药物输送系统，可以治疗早产或产后出血，这些都是主要的临床问题。我们寻求支持，以在人类研究之前，在小鼠和灵长类动物早产模型中证明它们的有效性。

We have patented liposomes targeted to the uterus, which enable us to deliver drugs specifically to the muscle cells of the uterus, increasing safety. The liposomes can be loaded with drugs that either block or promote contractions, creating a versatile drug delivery system that could treat premature labour or postpartum haemorrhage which are major clinical problems. We seek support to demonstrate their effectiveness in mouse and primate models of preterm labour prior to human studies.